Todd Usen, appointed leader of the Board of Directors last July, visited the Rob Surgical facilities a few weeks ago. During the visit he was able to meet the entire team, attend the live operations carried out by the Bitrack robotic system and work alongside the CEO, Jaume Amat, on the company’s next challenges.
Todd’s collaboration will be essential in the commercialization stage of the Bitrack System open robotic platform, which aims to enter hospitals in 2024 after receiving European certification, which is already in the final phase.
Todd Usen will lead the commercialization project that will allow us to meet the goal of having 50 units of the surgical platform installed in hospitals throughout Europe by 2025, as well as the intensive use of the robot in more than 500 surgeries in the urological field. His contribution and global experience will be key to designing and implementing the installation plan for the first 50 units, as well as offering advice and support to hospital centers that will act as early adopters of Bitrack technology.
During the visit, Todd congratulated the team for their progress and thanked them for their dedication and efforts to universalize the benefits of precision surgery, which will undoubtedly bring benefits to patients, surgeons and hospitals around the world.
“It has been fantastic meeting the team at Rob Surgical. All of them are the reason why I deeply believe in Rob Surgical. I have felt very welcomed and I am looking forward to learning from them and working together.” declared Todd Usen, in an interview that will soon be available on this blog. “I have been absolutely impressed by the capabilities and possibilities of Bitrack. Listening to the surgeons’ feedback after a live operation has been very motivating and confirms the good future prospects.”
It is a privilege to have Todd’s talent, experience, energy and dedication. Todd is a highly respected MedTech executive with extensive experience in growth companies and corporate governance. For the past 25 years, Todd has served as Chairman, Non-Executive Director and CEO leading organizations from technology concept to FDA approval and CE marking.
“Todd is an experienced professional who shares our purpose and values. We look forward to working closely with him to take Rob Surgical to the next level,” highlights Jaume Amat, CEO of Rob Surgical.
